Medscape |
SGLT2 Inhibitors in Type 1 Diabetes
Medscape Current guidelines from the American Diabetes Association (ADA) support an intensive insulin regimen for T1D, citing the Diabetes Control and Complications Trial, which demonstrated improvements in vascular and all-cause mortality outcomes with such a ... |
from diabetes - Google News
Social Plugin